The Disruptive Nature of Personalized Medicine Technologies: Implications for the Health Care System

Publisher： Karger

E-ISSN： 1662-8063|12|3|180-184

ISSN： 1662-4246

Source： Public Health Genomics, Vol.12, Iss.3, 2009-02, pp. : 180-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized Medicine in the NICU

By Barrington Keith J.  

American Journal of Bioethics, Vol. 13, Iss. 12, 2013-12 ,pp. : 33-35

Routledge Ltd

Access to resources Recommend Favorite

Mitochondrial antibiograms in personalized medicine

By Pacheu-Grau David   Gómez-Durán Aurora   Iglesias Eldris   López-Gallardo Ester   Montoya Julio   Ruiz-Pesini Eduardo  

Human Molecular Genetics, Vol. 22, Iss. 6, 2013-03 ,pp. : 1132-1139

Oxford University Press

Access to resources Recommend Favorite

Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine

By  

Public Health Genomics, Vol. 18, Iss. 5, 2015-0 ,pp. : 249-259

Karger

Access to resources Recommend Favorite

A Health Services Research Agenda for Cellular, Molecular and Genomic Technologies in Cancer Care

By  

Public Health Genomics, Vol. 12, Iss. 4, 2009-02 ,pp. : 233-244

Karger

Access to resources Recommend Favorite

Genetics and Vaccines in the Era of Personalized Medicine

By  

Current Genomics, Vol. 16, Iss. 1, 2015-02 ,pp. : 47-59

Bentham Science Publishers

Access to resources Recommend Favorite